Video: Novo CEO: Aim to expand U.S. weight-loss marked
-
Mike Doustdar, CEO of Novo Nordisk, discusses the company's GLP-1 pill following the release of the company's Q1 earnings.
-
Hvor er det et fint interwiev... Meget andeledes end det med CEO fra EL forleden. -Der er gode insights, gode spørgsmål og behagelig tilstedeværelse.. Jeg synes, Mike D. gør det godt!! - Ikke mindst som sælger i mange sammenhænge - som i denne. Hele narrativet: Tiderne skifter! - bliver sunget ind som et enkelt - men gentaget tema.
-
CNBC's Angelica Peebles speaks with Novo Nordisk CEO Mike Doustdar about the company's quarterly report, the strong launch of the Wegovy pill and what else Novo Nordisk has to come in the pipeline. He says he's always open to doing deals that will strengthen the portfolio and it's part of the company's mindset not to become to complacent or arrogant about Novo's "fantastic" pipeline as it stands.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind